● Single award · contract
Advanced Research and Development and Delivery of Adult and Pediatric Midazolam Autoinjectors That Have…
A single federal award, with both ends of the trail linked.
$104.2M
total award value
2022
action date
60 mo
period
75A50122C00031
PIID
Description
Advanced Research and Development and Delivery of Adult and Pediatric Midazolam Autoinjectors That Have Received Emergency Use Authorization (Eua) or FDA Approval for the Treatment of Status Epilepticus Seizures in Adult and Pediatric Populations (2+
Awarding agencyDepartment of Health and Human Services →
RecipientOutside our Phase 1 contractor set: see methodology
Place of performance—
CategoryNAICS 541714PSC AN13
Competed?Not recorded✓ from source
Total (exact)$104,152,986
More from Department of Health and Human Services
awarded 2024$100.1B
awarded 2023$92B
awarded 2022$80.5B
awarded 2021$80.5B
awarded 2022$71.7B
🔎
Why the labels? The graph is only worth anything if the links are trusted. Facts taken straight from a federal filing are ✓ from source; anything we compute or infer (corporate parents, districts, competitors) is ≈ inferred and worded carefully, never asserted as fact.